| Description | Mirikizumab (LY3074828), a humanized IgG4 monoclonal antibody, specifically targets the p19 subunit of interleukin 23. It is currently under research for its potential application in treating ulcerative colitis [1]. |
| molecular weight | N/A |
| CAS | 1884201-71-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |